Retension Pharmaceuticals

RTSN

12.2700.16% ( +0.020 )

已收盘: 11月13日 16:00:00 (美东)

股东类型

公众及其他54.35%
个人与内部人士23.62%
机构投资者12.03%
对冲基金10.00%

主要股东

主要股东最新
股东
PVG Asset Management Corp	12.03%	100.21 万	--	+100.21 万	2026/10/09
The B Group, Inc.	10.00%	83.33 万	--	+83.33 万	2026/10/13
Laurence Lytton	7.41%	61.72 万	--	+61.72 万	2026/10/13
Eric KellerCo-founder, CEO & Director	5.57%	46.44 万	--	+46.44 万	2026/10/13
Craig SincockFormer Director	5.26%	43.85 万	--	+43.85 万	2026/10/09
Paul SweetnamCo-Founder, Chief Scientific Officer & Secretary	4.91%	40.92 万	--	+40.92 万	2026/10/13
Franklin BergerIndependent Director	0.27%	2.25 万	--	+2.25 万	2026/10/13
Michael BerendtExecutive Chairman	0.08%	6,666.00	--	+6,666.00	2026/10/13
Donald OldsIndependent Director	0.07%	5,637.00	--	+5,637.00	2026/10/13
Sabine BissonChief Operations Officer	0.05%	4,115.00	--	+4,115.00	2026/10/13